Phase 2b Results of Parkinson’s Disease Drug Presented by Acorda
Acorda Therapeutics recently presented results from a Phase 2b study of its investigational drug CVT-301 in patients with Parkinson’s disease (PD)…
Articles by Ana de Barros, PhD
European Patent Issued for Aeolus’ Parkinson’s Disease Treatment, and Patent Allowed in Japan
A European patent has been issued covering the composition of matter for Aeolus Pharmaceuticals’ AEOL 11114, an oral Parkinson’s disease…
Cynapsus and MonoSol Enter Licensing Agreement for Sublingual Film Treatment of Parkinson ‘Off’ Episodes
Cynapsus Therapeutics and MonoSol Rx announced that they have signed a global licensing agreement for select intellectual property, including existing and future…
Newron and Zambon Support Parkinson’s Disease Awareness Day, Focus on Advancing Xadago
Italy-based biopharma Newron Pharmaceuticals S.p.A. and its partner, international pharmaceutical company Zambon S.p.A., both dedicated to finding treatments for…
Drugs to Control Parkinson’s Tremors May Increase Risk of Impulse Control Disorders
Neurologists reported that drugs commonly prescribed for Parkinson’s disease are associated in some people with impulse control disorders such as pathological gambling…
‘Spotlight on Hope’ Gala to Raise Awareness and Funds for Neurological Disorders
The Colorado Neurological Institute (CNI), a research discovery nonprofit that focuses on neurological care, will host its inaugural Spotlight…
Journal of Parkinson’s Disease Adds a Tool for Finding Sources of Research Funding to Its Website
The Journal of Parkinson’s Disease (JPD) is working to promote Parkinson’s research by helping its researchers find new sources of…
FDA Advisory Committee Concludes Nuplazid Beneficial for Parkinson’s Disease Psychosis Treatment
ACADIA Pharmaceuticals accounced that the FDA Psychopharmacologic Drugs Advisory Committee voted that the benefits of Nuplazid (pimavanserin) for the…
Potential Disease-Modifying Therapy for Parkinson’s Enters Phase 2b Study in New Zealand
Living Cell Technologies announced that it has received approval from the Auckland Hospital Research Review Committee to begin a Phase 2b clinical…
Free Webinar to Explain New Parkinson’s Research to Be Hosted by FMM and Partner Groups
The free Hope Flies Health Series Webinar: Research Connecting Parkinson’s Disease and Mitochondrial Disease is scheduled for 1 p.m. Eastern Standard…